"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Injection, USP 50%
2.03 mM/mLof Magnesium Sulfate (magnesium sulfate (magnesium sulfate injection) injection) heptahydrate
Osmolarity 4.06 mOsmol/mL
MUST BE DILUTED PRIOR TO IV ADMINISTRATION
Magnesium Sulfate Injection, USP (50%) for IV and IM use is a sterile concentrated solution of magnesium sulfate (magnesium sulfate (magnesium sulfate injection) injection) USP. Each mL contains: magnesium sulfate (magnesium sulfate (magnesium sulfate injection) injection) (heptahydrate) 500 mg, which provides 4.06 mEq each of magnesium (Mg++) and sulfate (SO4=), water for injection q.s. The pH (5.5 - 7.0) is adjusted with sulfuric acid and/or sodium hydroxide. The solution contains no bacteriostatic agent or other preservatives. The molecular formula is MgSO4•7H2O and the molecular weight is 246.47.
What are the possible side effects of magnesium sulfate injection (Magnesium Sulfate-Sodium Chloride, Sulfamag)?
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Tell your caregiver right away if you have a serious side effect such as:
- feeling like you might pass out;
- sweating, anxiety, cold feeling;
- flushing (warmth, redness, or tingly feeling);
- weak or shallow breathing;
- extreme drowsiness, feeling very weak; or
- numbness or tingly feeling around your mouth, muscle tightness or...
Last reviewed on RxList: 8/11/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Magnesium Sulfate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.